Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
4.68%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 10.05Close
$ 3.7 - $ 11.11 52-Week Range
Ticker Information
Ticker
GLUECompany Name
MONTE ROSA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQMONTE ROSA THERAPEUTICS INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
GLUE - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 8.34M | 4.68% | $ 177.99M |
| 3/31/2025 | $ 8.27M | 5.19% | $ 159.49M |
| 12/31/2024 | $ 8.12M | 10.74% | $ 75.62M |
| 9/30/2024 | $ 7.91M | 52.79% | $ 14.97M |
| 6/30/2024 | $ 7.64M | 132.61% | $ 5.76M |
| 3/31/2024 | $ 6.97M | 654.89% | $ 1.06M |
| 12/31/2023 | $ 6.22M | 0% | $ 0 |
| 9/30/2023 | $ 7.06M | 0% | $ 0 |
| 6/30/2023 | $ 7.8M | 0% | $ 0 |
| 3/31/2023 | $ 8.58M | 0% | $ 0 |
Key Performance Insights, Last 5 Years
- MONTE ROSA THERAPEUTICS INC's latest trailing twelve months (TTM) DepAmor % stands at 0%.
- Over the past 5 years, MONTE ROSA THERAPEUTICS INC's average DepAmor % has been 143.48%.
- The median DepAmor % for MONTE ROSA THERAPEUTICS INC during this period was 31.77%
- MONTE ROSA THERAPEUTICS INC reached its highest DepAmor % over the past 5 years at 654.89%.
- The lowest DepAmor % recorded by MONTE ROSA THERAPEUTICS INC in the same timeframe 4.68%
MONTE ROSA THERAPEUTICS INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for MONTE ROSA THERAPEUTICS INC is calculated as follows: DepAmor [ $ 537K ] / Revenues [ $ 0 ]
(=) DepAmor % [ 0% ] GLUE - Depreciation and Amortization Margin, Last 5 years
4.68%
Minimum
Jun 30, 2025
654.89%
Maximum
Mar 31, 2024
143.48%
Average
31.77%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.13%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.32K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.2% |
| std | 5.13% |